UnitedHealth Raises 2026 Outlook To At Least $20.50 Adjusted Per Share As Medical Cost Ratio Falls To 88.4%

Third-quarter adjusted earnings were $4.69 per share against $2.92 a year earlier, while revenue slipped to $112.7 billion.

Share
UnitedHealth Raises 2026 Outlook To At Least $20.50 Adjusted Per Share As Medical Cost Ratio Falls To 88.4%

UnitedHealth Group raised its 2026 outlook to adjusted earnings of at least $20.50 per share, the company said in third-quarter results furnished with an 8-K on Tuesday. Standard-accounting earnings are now guided to at least $19.50 per share.

What the results show

Third-quarter adjusted earnings were $4.69 per share, versus $2.92 a year earlier. Standard-accounting earnings were $4.56, versus $2.59.

Earnings from operations rose to $6.6 billion from $4.3 billion, on revenue of $112.7 billion, down from $113.2 billion. Net margin was 3.6%, against 2.1% a year ago.

The medical care ratio, the share of premiums spent on patient care, fell to 88.4% from 89.9%. The company said the figure includes $610 million of net favorable reserve development tied to 2026 dates of service. The operating cost ratio was 12.8%, versus 13.5%.

Cash flow from operations was $5.1 billion, or 1.2 times net income. The debt-to-capital ratio was 41.7% at September 30, versus 41.2% in the second quarter. For the first nine months, the company repurchased $5.0 billion of stock and paid $6.2 billion in dividends.

Where membership and revenue moved

Optum Health earned $735 million from operations, versus $41 million a year earlier. Its revenue fell 10% to $22.9 billion because it served fewer value-based care patients.

UnitedHealthcare earned $2.8 billion on $86.3 billion of revenue, versus $1.8 billion on $87.1 billion. Medicare Advantage seniors have contracted by 935,000 since year-end 2025, though the customer table shows 7.605 million in September, up from 7.565 million in June. Medicaid served 6.695 million, down from 6.78 million in June, which the company tied to eligibility changes.

Optum Rx earned $1.7 billion, versus $1.5 billion, while adjusted scripts fell to 393 million from 414 million.

Company commitments

CEO Stephen Hemsley said the results reflect "the discipline and execution our teams are bringing to every part of our business."

The release lists a $1 billion commitment to the United Health Foundation and plans to rebate 2026 profits on individual Affordable Care Act plans to about 1 million members. It also targets eliminating 30% of current prior approval volume by the end of 2026, and says further commitments are expected in 2027.

UnitedHealth held its investor call at 8:00 a.m. Eastern on Tuesday, with a webcast replay available through October 27, 2026.

Sources